Letter: Interaction between thyroxine and 35-S-labelled antithyroid drugs.
D000818:Animals; D013956:Antithyroid Agents / Q000378:metabolism*; D002845:Chromatography; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006207:Half-Life; D006801:Humans; D006980:Hyperthyroidism / Q000097:blood / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D008297:Male; D008713:Methimazole / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D011485:Protein Binding; D051381:Rats; D013462:Sulfur Radioisotopes; D013961:Thyroid Gland / Q000032:analysis / Q000378:metabolism; D013974:Thyroxine / Q000008:administration & dosage / Q000378:metabolism* / Q000627:therapeutic use
D013956:Antithyroid Agents; D013462:Sulfur Radioisotopes; D008713:Methimazole; D013974:Thyroxine